247 related articles for article (PubMed ID: 27511850)
1. Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Cui Y; Song J; Pollom E; Alagappan M; Shirato H; Chang DT; Koong AC; Li R
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):102-9. PubMed ID: 27511850
[TBL] [Abstract][Full Text] [Related]
2. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
Wu J; Aguilera T; Shultz D; Gudur M; Rubin DL; Loo BW; Diehn M; Li R
Radiology; 2016 Oct; 281(1):270-8. PubMed ID: 27046074
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy.
Ren S; Zhu X; Zhang A; Li D; Zuo C; Zhang H
Cancer Imaging; 2020 Mar; 20(1):22. PubMed ID: 32156306
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
5. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.
Dholakia AS; Chaudhry M; Leal JP; Chang DT; Raman SP; Hacker-Prietz A; Su Z; Pai J; Oteiza KE; Griffith ME; Wahl RL; Tryggestad E; Pawlik T; Laheru DA; Wolfgang CL; Koong AC; Herman JM
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):539-46. PubMed ID: 24751410
[TBL] [Abstract][Full Text] [Related]
6. Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors.
Fried DV; Mawlawi O; Zhang L; Fave X; Zhou S; Ibbott G; Liao Z; Court LE
Radiology; 2016 Jan; 278(1):214-22. PubMed ID: 26176655
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of 18F-FDG PET/CT metabolic parameters and clinical figures in locally advanced pancreatic cancer underwent chemotherapy combined with stereotactic body radiation therapy.
Zhang A; Ren S; Yuan Y; Li X; Zhu X; Jiang L; Li D; Zuo C
Medicine (Baltimore); 2019 Mar; 98(13):e15064. PubMed ID: 30921238
[TBL] [Abstract][Full Text] [Related]
8. Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
Wu J; Gensheimer MF; Dong X; Rubin DL; Napel S; Diehn M; Loo BW; Li R
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1504-1512. PubMed ID: 27212196
[TBL] [Abstract][Full Text] [Related]
9. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
[TBL] [Abstract][Full Text] [Related]
11. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
12. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
Sun Y; Lu P; Yu L
Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
[TBL] [Abstract][Full Text] [Related]
13. Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer.
Wang SL; Cao S; Sun YN; Wu R; Chi F; Tang MY; Jin XY; Chen XD
Abdom Imaging; 2015 Oct; 40(8):3117-21. PubMed ID: 26350284
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer.
Chen BB; Tien YW; Chang MC; Cheng MF; Chang YT; Yang SH; Wu CH; Kuo TC; Shih IL; Yen RF; Shih TT
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1205-1217. PubMed ID: 29476229
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.
Cozzi L; Comito T; Fogliata A; Franzese C; Franceschini D; Bonifacio C; Tozzi A; Di Brina L; Clerici E; Tomatis S; Reggiori G; Lobefalo F; Stravato A; Mancosu P; Zerbi A; Sollini M; Kirienko M; Chiti A; Scorsetti M
PLoS One; 2019; 14(1):e0210758. PubMed ID: 30657785
[TBL] [Abstract][Full Text] [Related]
16. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
[TBL] [Abstract][Full Text] [Related]
18. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
[TBL] [Abstract][Full Text] [Related]
19. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
